JD Health is JD.com's spun-out healthcare subsidiary that operates a multifunctional online health platform in China. Its offerings include 30-minute pharmacy delivery, telemedicine (which saw surging usage during the COVID-19 pandemic), consumer services such as genetic testing, and solutions to digitize hospital systems. The company’s CEO Xin Lijun said the business "achieved profitability" last year. As of May, its online drugstore had over 190 million annual active consumers; since the COVID-19 outbreak more than 1.7 million patients have used its diagnosis service, which now handles over 100,000 inquiries daily. JD Health has pledged to construct an online family doctor service targeting as many as 50 million Chinese families. The unit was spun out as a subsidiary last May as part of JD.com's effort to expand beyond retail and prepare for a potential IPO.

Total raised

$830M

Funding rounds

1

Latest round

Series B

Latest activity

Aug 2020